Covered recipient · General Payments record
GINA LYNETTE YOUNG-HARPER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$782.69
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $227.31 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $70.53 | 4 |
| Acerta Pharma LLC | $43.31 | 2 |
| ABBVIE INC. | $24.35 | 1 |
| Exact Sciences Corporation | $21.29 | 1 |
| Lilly USA, LLC | $20.65 | 1 |
| Supernus Pharmaceuticals, Inc. | $17.16 | 1 |
| Amgen Inc. | $15.05 | 1 |
| Teva Pharmaceuticals USA, Inc. | $14.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.35 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454250 | CMS |
| Amgen Inc. | $15.05 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116220248 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.65 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104264573 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.66 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104448137 | CMS |
| Exact Sciences Corporation | $21.29 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114957016 | CMS |
| Lilly USA, LLC | $20.65 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135651331 | CMS |
| Novo Nordisk Inc | $17.19 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100452214 | CMS |
| Novo Nordisk Inc | $13.13 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100428121 | CMS |
| Novo Nordisk Inc | $24.14 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100542458 | CMS |
| Novo Nordisk Inc | $16.07 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100472009 | CMS |
| Supernus Pharmaceuticals, Inc. | $17.16 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147874689 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.97 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151595507 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.